Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections

Journal of Heart and Lung Transplantation

Volumn 35, Issue 1, 2016, Pages 108-114

  Cagliostro, Barbara ^a   Levin, Allison P ^b   Fried, Justin ^b   Stewart, Scott ^a   Parkis, Grant ^a   Mody, Kanika P ^b   Garan, Arthur R ^b   Topkara, Veli ^b   Takayama, Hiroo ^a   Naka, Yoshifumi ^a   Jorde, Ulrich P ^c   Uriel, Nir ^d  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

CFLVAD; driveline; infection; kit; reduction; silver dressing

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; BACTEREMIA; BANDAGES AND DRESSINGS; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEBRIDEMENT; DRIVELINE INFECTION; FEMALE; FOLLOW UP; GAUZE DRESSING; HOSPITAL READMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUMP POCKET INFECTION; RISK FACTOR; RISK REDUCTION; SILVER DRESSING; STANDARD ANCHORING DEVICE; ADVERSE EFFECTS; HEART ASSIST DEVICE; HEART FAILURE; PRACTICE GUIDELINE; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDY; UNITED STATES;

FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84954076683     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.06.010     Document Type: Article

References (21)

1. S.A. Hunt, and R. Ea The REMATCH trial: long-term use of a left ventricular assist device for end-stage heart failure J Card Fail 8 2002 59 60
2. N. Uriel, J. Han, K.A. Morrison, and et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon J Heart Lung Transplant 33 2014 51 59
3. M.S. Slaughter, F.D. Pagani, E.C. McGee, and et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
4. W.L. Holman, D.C. Naftel, C.E. Eckert, and et al. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 J Thorac Cardiovasc Surg 146 2013 437-41.e1
5. R.J. Gordon, A.D. Weinberg, F.D. Pagani, and et al. Prospective, multicenter study of ventricular assist device infections Circulation 127 2013 691 702
6. D.J. Goldstein, D. Naftel, W. Holman, and et al. Continuous-flow devices and percutaneous site infections: clinical outcomes J Heart Lung Transplant 31 2012 1151 1157
7. V.K. Topkara, S. Kondareddy, F. Malik, and et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era Ann Thorac Surg 90 2010 1270 1277
8. F.D. Pagani, L.W. Miller, S.D. Russell, and et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
9. The Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs). http://www.uab.edu/medicine/intermacs/appendices-4-0/appendix-a-4-0. Accessed August 31, 2015.
10. L.W. Miller, F.D. Pagani, S.D. Russell, and et al. Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
11. U.P. Jorde, S.S. Kushwaha, A.J. Tatooles, and et al. Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist Device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 63 2014 1751 1757
12. M.S. Slaughter, F.D. Pagani, E.C. McGee, and et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
13. B.A. Whitson, P. Eckman, F. Kamdar, and et al. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients Ann Thorac Surg 97 2014 2097 2103
14. T.S. Kato, P.C. Schulze, J. Yang, and et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device J Heart Lung Transplant 31 2012 1 8
15. M. Hieda, M. Sata, O. Seguchi, and et al. Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device Transplant Proc 46 2014 907 910
16. F. Jiritano, G.F. Serraino, M. Rossi, and et al. Ventricular assist device driveline infection: treatment with platelet-rich plasma Ann Thorac Surg 96 2013 e37 e38
17. J.J. Nienaber, S. Kusne, T. Riaz, and et al. Clinical manifestations and management of left ventricular assist device-associated infections Clin Infect Dis 57 2013 1438 1448
18. B.W. Sperry, O. Fatemi, M.E. Ruiz, and et al. Late manifestation of a driveline infection after heart transplantation J Heart Lung Transplant 33 2014 324 325
19. V. Walter, U.A. Stock, M. Soriano-Romero, and et al. Eradication of a chronic wound and driveline infection after redo-LVAD implantation J Cardiothorac Surg 9 2014 63
20. S.A. Akhter, M.J. Russo, A. Singh, and et al. Modified HeartMate II driveline externalization technique significantly decreased incidence of infection and improves long-term survival J Heart Lung Transplant 31 2012 S20
21. S. Maniar, S. Kondareddy, and V.K. Topkara Left ventricular assist device-related infections: past, present and future Exp Rev Med Dev 8 2011 627 634